Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients

por Metz, Michael, Semsek, Dieter, Rogmans, Gunther, Hutzschenreuter, Ulrich, Fietz, Thomas, Harde, Johanna, Zacharias, Stefan, Hielscher, Carsten, Lorenz, Andreas, Zahn, Mark-Oliver, Guth, Dagmar, Liebers, Steffen, Berghorn, Michael, Grebhardt, Sina, Matillon, Christiane D., Egerer, Gerlinde, Potthoff, Karin
Publicado 2021

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

por Fasching, Peter A, Jud, Sebastian M, Hauschild, Maik, Kümmel, Sherko, Schütte, Martin, Warm, Matthias, Hanf, Volker, Grab, Dieter, Krocker, Jutta, Stickeler, Elmar, Kreienberg, Rolf, Müller, Thomas, Kühn, Thorsten, Wolf, Christopher, Kahlert, Steffen, Paepke, Stefan, Berghorn, Michael, Muth, Mathias, Baier, Monika, Wackwitz, Birgit, Schulz-Wendtland, Rüdiger, Beckmann, Matthias W, Lux, Michael P
Publicado 2014